Target- |
MechanismLipolysis modulators |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
An Open Label Phase 2 Study to Evaluate the Effects of a Local Anesthetic, Anti-inflammatory Medications and Compression Garments on RZL-012-Induced Adverse Events
This is a Phase 2, open-label, 2-stage, adaptive-design study in which subjects will be randomized into one of 5 treatment groups comprised of RZL-012 with or without additional study treatments:
100 Clinical Results associated with Raziel Health LLC
0 Patents (Medical) associated with Raziel Health LLC
100 Deals associated with Raziel Health LLC
100 Translational Medicine associated with Raziel Health LLC